Clostridium difficile infection in a patient with Crohn disease

Journal of the Formosan Medical Association

Volumn 111, Issue 6, 2012, Pages 347-349

  Hsu, Chien Hui ^a   Jeng, Yung Ming ^a   Ni, Yen Hsuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Children; Clostridium difficile; Crohn disease; Inflammatory bowel disease

Indexed keywords

ALBUMIN; AZATHIOPRINE; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE TOXIN A; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE DISEASE; ADOLESCENT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BLOODY DIARRHEA; CASE REPORT; CELL INFILTRATION; CLOSTRIDIUM DIFFICILE INFECTION; COLON MUCOSA; COLONOSCOPY; CROHN DISEASE; CRYPT CELL; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGOGASTRODUODENOSCOPY; FECES CULTURE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE POLYP; INTESTINE ULCER; LAMINA PROPRIA; LEUKOCYTE AGGREGATION; RECURRENT DISEASE; SUBMUCOSA;

ADOLESCENT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS;

EID: 84862881300     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2009.09.001     Document Type: Article

References (12)

1. Thoreson R., Cullen J.J. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am 2007, 87:575-585.
2. Hyams J., Markowitz J., Otley A., Rosh J., Mack C., Bousvaros A., et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005, 41:416-421.
3. Delmée M. Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 2001, 8:411-416.
4. Dubberke E.R., Reske K.A., Yan Y., Olsen M.A., McDonald L.C., Fraser V.J. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007, 45:1543-1549.
5. Conte M.P., Schippa S., Zamboni I., Penta M., Chiarini F., Seganti L., et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006, 55:1760-1767.
6. Eckburg P.B., Relman D.A. The role of microbes in Crohn's disease. Clin Infect Dis 2007, 44:256-262.
7. Stone C.D. Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Gut 2008, 57:150-152.
8. Yang Z., Fuss I.J., Watanabe T., Asano N., Davey M.P., Rosenbaum J.T., et al. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology 2007, 133:1510-1521.
9. Hsiao C.H., Wei S.C., Wong J.M., Lai H.S., Chang M.H., Ni Y.H. Pediatric Crohn disease: clinical and genetic characteristics in Taiwan. J Pediatr Gastroenterol Nutr 2007, 44:342-346.
10. Issa M., Ananthakrishnan A.N., Binion D.G. Clostridium difficile and Inflammatory Bowel Disease. Inflamm Bowel Dis 2008, 14:1432-1442.
11. Bricker E., Garg R., Nelson R., Loza A., Novak T., Hansen J. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2005, CD004610.
12. Issa M., Vijayapal A., Graham M.B., Beaulieu D.B., Otterson M.F., Lundeen S., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345-351.